Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
May 30, 2018
Evaluation of Parameters Related to the Probability of Leukemic Progression in Patients With Lower-Risk Myelodysplastic Syndrome
Jose F Falantes, Francisco J Márquez-Malaver, Cristina Calderón-Cabrera, et al.
Leukemia & Lymphoma
|
December 14, 2016
The incorporation of comorbidities in the prognostication of patients with lower-risk myelodysplastic syndrome
Jose F Falantes, Francisco J Márquez-Malaver, Teresa Knight, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 22, 2014
Mismatch on glutathione S-transferase T1 increases the risk of graft-versus-host disease and mortality after allogeneic stem cell transplantation
María José Martínez-Bravo, Cristina Calderón-Cabrera, Francisco José Márquez-Malaver, et al.
Transfusion
|
October 31, 2014
Intermediate doses of cytarabine plus granulocyte-colony-stimulating factor as an effective and safe regimen for hematopoietic stem cell collection in lymphoma patients with prior mobilization failure
Cristina Calderón-Cabrera, Magdalena Carmona González, Jesús Martín, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 29, 2018
Allocation to Matched Related or Unrelated Donor Results in Similar Clinical Outcomes without Increased Risk of Failure to Proceed to Transplant among Patients with Acute Myeloid Leukemia: A Retrospective Analysis from the Time of Transplant Approval
Eduardo Rodríguez-Arbolí, Francisco José Márquez-Malaver, Nancy Rodríguez-Torres, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
June 6, 2015
Intra-arterial bone marrow mononuclear cells (BM-MNCs) transplantation in acute ischemic stroke (IBIS trial): protocol of a phase II, randomized, dose-finding, controlled multicenter trial
Francisco Moniche, Irene Escudero, Elena Zapata-Arriaza, et al.
Hematological Oncology
|
November 20, 2014
Role of 18F-FDG-PET/CT in the management of marginal zone B cell lymphoma
Estrella Carrillo-Cruz, Victor A Marín-Oyaga, Fátima de la Cruz Vicente, et al.
European Journal of Haematology
|
March 5, 2019
Frequency, characteristics, and outcome of PTLD after allo-SCT: A multicenter study from the Spanish group of blood and marrow transplantation (GETH)
Irene García-Cadenas, Lucrecia Yáñez, Isidro Jarque, et al.
Annals of Hematology
|
July 18, 2019
Chronic graft-versus-host disease could ameliorate the impact of adverse somatic mutations in patients with myelodysplastic syndromes and hematopoietic stem cell transplantation
Juan Carlos Caballero, Mercedes Sánchez Barba, Jesús María Hernández Sánchez, et al.
Leukemia Research
|
December 10, 2014
Multivariable time-dependent analysis of the impact of azacitidine in patients with lower-risk myelodysplastic syndrome and unfavorable specific lower-risk score
Jose Falantes, Regina García Delgado, Cristina Calderón-Cabrera, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Clinical Lymphoma, Myeloma & Leukemia
|
May 30, 2018
Evaluation of Parameters Related to the Probability of Leukemic Progression in Patients With Lower-Risk Myelodysplastic Syndrome
Jose F Falantes, Francisco J Márquez-Malaver, Cristina Calderón-Cabrera, et al.
Leukemia & Lymphoma
|
December 14, 2016
The incorporation of comorbidities in the prognostication of patients with lower-risk myelodysplastic syndrome
Jose F Falantes, Francisco J Márquez-Malaver, Teresa Knight, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 22, 2014
Mismatch on glutathione S-transferase T1 increases the risk of graft-versus-host disease and mortality after allogeneic stem cell transplantation
María José Martínez-Bravo, Cristina Calderón-Cabrera, Francisco José Márquez-Malaver, et al.
Transfusion
|
October 31, 2014
Intermediate doses of cytarabine plus granulocyte-colony-stimulating factor as an effective and safe regimen for hematopoietic stem cell collection in lymphoma patients with prior mobilization failure
Cristina Calderón-Cabrera, Magdalena Carmona González, Jesús Martín, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 29, 2018
Allocation to Matched Related or Unrelated Donor Results in Similar Clinical Outcomes without Increased Risk of Failure to Proceed to Transplant among Patients with Acute Myeloid Leukemia: A Retrospective Analysis from the Time of Transplant Approval
Eduardo Rodríguez-Arbolí, Francisco José Márquez-Malaver, Nancy Rodríguez-Torres, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
June 6, 2015
Intra-arterial bone marrow mononuclear cells (BM-MNCs) transplantation in acute ischemic stroke (IBIS trial): protocol of a phase II, randomized, dose-finding, controlled multicenter trial
Francisco Moniche, Irene Escudero, Elena Zapata-Arriaza, et al.
Hematological Oncology
|
November 20, 2014
Role of 18F-FDG-PET/CT in the management of marginal zone B cell lymphoma
Estrella Carrillo-Cruz, Victor A Marín-Oyaga, Fátima de la Cruz Vicente, et al.
European Journal of Haematology
|
March 5, 2019
Frequency, characteristics, and outcome of PTLD after allo-SCT: A multicenter study from the Spanish group of blood and marrow transplantation (GETH)
Irene García-Cadenas, Lucrecia Yáñez, Isidro Jarque, et al.
Annals of Hematology
|
July 18, 2019
Chronic graft-versus-host disease could ameliorate the impact of adverse somatic mutations in patients with myelodysplastic syndromes and hematopoietic stem cell transplantation
Juan Carlos Caballero, Mercedes Sánchez Barba, Jesús María Hernández Sánchez, et al.
Leukemia Research
|
December 10, 2014
Multivariable time-dependent analysis of the impact of azacitidine in patients with lower-risk myelodysplastic syndrome and unfavorable specific lower-risk score
Jose Falantes, Regina García Delgado, Cristina Calderón-Cabrera, et al.
Page
of 2